Clozapine/fluvoxamineLack of efficacy (clozapine) reversed with fluvoxamine, and interaction leading to mania: 4 case reports

被引：0
作者：
机构：
来源：
Reactions Weekly | 2008年 / 1229卷 / 1期
关键词：
Clozapine; Fluvoxamine; CYP1A2 Genotyping; Clozapine Dose; Clozapine Concentration;
D O I：
10.2165/00128415-200812290-00030
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
[41]   Clozapine interactionFirst report of an interaction with concomitant nefazodone leading to hypotension, anxiety and dizziness: case report [J].
Reactions Weekly, 2001, 860 (1) :9-9
[42]   Clozapine interactionFirst report of an interaction with concomitant modafinil leading to gait disturbance and hypoxaemia: case report [J].
Reactions Weekly, 2002, 915 (1) :7-7
[43]   Clozapine interactionInteraction with valproic acid leading to agranulocytosis: case report [J].
Reactions Weekly, 2003, 939 (1) :8-8
[44]   Clozapine interactionInteraction with concomitant ciprofloxacin leading to rhabdomyolysis: case report [J].
Reactions Weekly, 2007, 1173 (1) :11-11
[45]   Clozapine interactionInteraction with concomitant phenytoin leading to neutropenia: case report [J].
Reactions Weekly, 2004, 1024 (1) :9-9
[46]   Clozapine interactionInteraction with concomitant diazepam leading to syncope: case report [J].
Reactions Weekly, 1999, 775 (1) :8-8
[47]   In-vitro and in-vivo evaluation of the drug-drug interaction between fluvoxamine and clozapine [J].
W.-H. Chang ;
Bruce Augustin ;
Hsien-Yuan Lane ;
Troy ZumBrunnen ;
Hui-Ching Liu ;
Yusuf Kazmi ;
Michael W. Jann .
Psychopharmacology, 1999, 145 :91-98
[48]   OlanzapineNeutropenia in patients previously treated with clozapine: 2 case reports [J].
Reactions Weekly, 2001, 839 (1) :10-10
[49]   Case Reports: Clozapine for the Treatment of Catatonia in Autism Spectrum Disorder [J].
Thom, Robyn P. ;
McDougle, Christopher J. .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2022, 52 (06) :2855-2858
[50]   Depressive symptomatology during clozapine treatment: two case reports [J].
Altamura, AC ;
Bignotti, S ;
Tura, G ;
Curreli, R ;
Pioli, R .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1998, 8 (03) :239-240
12345